Alexa Julianne is a science writer whose background combines molecular biology, clinical laboratory science and psychedelic research. She holds a bachelor's degree in molecular, cell and developmental biology from the University of California, Los Angeles, and spent eight years working in oncology laboratory science before moving into clinical research. Her subsequent experience includes clinical research coordination and a clinical systems specialist role at MAPS. She has contributed research-based articles to Psychedelic Science Review on psychedelics and mental health. At The Brazen Word, her writing explores ketamine research and treatment delivery, connecting scientific findings with questions about how emerging therapies are understood and used.
